共 242 条
[1]
Atkins MB(2004)Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma Clin Cancer Res 10 6342S-6346S
[2]
Regan M(1998)Interleukin-2-induces development of denditric cells from cord blood CD34+ cells J Leukoc Biol 63 620-630
[3]
McDermott D(1998)Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity J Immunol 161 6238-6244
[4]
Bykovskaja SN(1999a)Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide J Exp Clin Cancer Res 18 173-179
[5]
Buffo MJ(1999b)Efficient induction of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene J Exp Clin Cancer Res 18 191-199
[6]
Bunker M(2004)Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG ODN adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection J Immunol 172 2137-2146
[7]
Zhang H(2005)More efficient induction of HLA-A*0201-restricted and CEA-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumour cells Clin Cancer Res 11 7554-7563
[8]
Majors A(2005)Interleukin-2 in the treatment of renal cell carcinoma and malignant melanoma Cancer Treat Res 126 263-287
[9]
Herbert M(2005)Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial J Transl Med 3 10-1457
[10]
Lokshin A(2000)Expression of functional IL-2 receptors on mature splenic dendritic cells Eur J Immunol 30 1453-5247